KRAS and non-small cell lung carcinoma: In the last decade, groundbreaking innovations like next-generation sequencing, the generation of genetically engineered mouse models like KRAS-driven NSCLC models, and comprehensive databases of human tumor molecular profiles have transformed our understanding of NSCLC.